Waves in the electromagnetic spectrum vary in length. As electromagnetic waves shorten, their energy increases. Radiation therapy uses electromagnetic waves to kills cancer cells by damaging their DNA. Superficial Radiotherapy (SRT) uses low-level x-ray energy to kill non-melanoma skin cancer cells.
There are three main considerations when treating patients with SRT:
Partnering with SkinCure Oncology gives you access to industry experts that are fluent in State-specific regulations. Using a high-frequency image guidance system helps to ensure the highest level of accuracy when targeting the cancer cells. When discussing treatment options with patients, it’s helpful to describe the advantage of image-guided SRT as “taking the blindfold off so we can see the cancer as we treat it”. Shorthand for image-guided SRT is IG-SRT, and it’s a vastly superior treatment option when compared to non-image-guided SRT, brachytherapy and other radiotherapy options.
IG-SRT not only improves targeting accuracy, it also plays a huge role in dosimetry. Without the advantage of image-guidance, radiotherapy solutions have to rely on fixed protocols for dosage delivered. With image guidance performed before each treatment, the dosage can be adjusted based on the effectiveness of previous treatment sessions. We call this approach to treatment “adaptive radiotherapy”. When you partner with SkinCure Oncology, you will have access to an image-guided adaptive radiotherapy protocol. It’s the gold standard for radiotherapy-based treatment of non-melanoma skin cancer and it results in a cure rate exceeding 99%.
Environmental safety is a top priority. Prior to deployment of the radiation therapy equipment, a room within the practice location must be converted into a radiation therapy suite. Specialized knowledge and experience is needed to do this right. Partnering with SkinCure Oncology makes it easy. We take into account physics guidelines and radiation shielding requirements, and have construction crews with extensive experience building out safe and attractive radiotherapy treatment rooms.
The SRT-100 Vision ™ uses a 100 kilovolt generator and an x-ray tube with a tungsten filament to generate an x-ray beam with peak voltage of 20 to 100 kVp.
The device has been cleared by the US FDA for the treatment of non-melanoma skin cancer.
Using a high-frequency ultrasound guidance system, the SRT-100 Vision™ provides three significant advantages over non-image-guided radiotherapy:
When it comes to killing non-melanoma skin cancer, IG-SRT has been shown to have superior outcomes. Please visit our Clinical Outcomes page to view the most recent studies on the effectiveness of IG-SRT.
Click here for a printable PDF of the cancer types.